As insulin shortages persist, what diabetes patients can do
Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported ...
pharmaphorum1 天
Sanofi turns the tables on Lilly with biosimilar fast-acting insulin
The FDA approved its short-acting insulin, Fiasp (insulin aspart injection ... safe and effective alternatives to brand name drugs approved through the agency’s abbreviated pathways.” ...
pharmaphorum1 个月
Novo Nordisk shadows Lilly with insulin price cut plan
The discount affects several of its older long- and short-acting insulin brands in both vial and pre-filled pen formats, including Levemir and Novolin, which will fall 65%, and the NovoLog and ...